> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Lotrimin Not Withdrawn Over Safety/Efficacy: FDA
- URL: https://www.fdaweb.com/lotrimin-not-withdrawn-over-safety-efficacy-fda/
- Published: 2019-02-14T12:00:00.000Z
- Updated: 2026-09-15T01:04:44.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5143389

*Federal Register* notice: FDA has determined that Schering-Plough Healthcare Products’ Lotrimin (clotrimazole) topical solution, 1%, was not withdrawn from sale for safety or effectiveness reasons. The determination means that FDA will not begin procedures to withdraw approval of ANDAs that refer to the product, and it will allow the agency to continue to approve ANDAs referencing it too as long as they meet relevant legal and regulatory requirements. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2019-02-13/pdf/2019-02139.pdf?ref=fdaweb.com).